Clinical trial
Safety and Efficacy Study of EPI-743 on Visual Function in Patients With Friedreich's Ataxia
NCT01728064 is registered in ClinicalTrials.gov with PTC Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy Study of EPI-743 on Visual Function in Patients With Friedreich's Ataxia
- Lead sponsor
- PTC Therapeutics
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 2012
- Completion date
- February 29, 2016
- Enrollment
- 60 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
friedreich's ataxia